DK183590A - Fremgangsmaade til reduktion af immunoglobulin e-responser - Google Patents

Fremgangsmaade til reduktion af immunoglobulin e-responser Download PDF

Info

Publication number
DK183590A
DK183590A DK183590A DK183590A DK183590A DK 183590 A DK183590 A DK 183590A DK 183590 A DK183590 A DK 183590A DK 183590 A DK183590 A DK 183590A DK 183590 A DK183590 A DK 183590A
Authority
DK
Denmark
Prior art keywords
responses
procedure
reducing immunoglobulin
antagonist
human interleukin
Prior art date
Application number
DK183590A
Other languages
Danish (da)
English (en)
Other versions
DK183590D0 (da
Inventor
Robert L Coffman
Jan Egbert De Vries
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22538655&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK183590(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of DK183590D0 publication Critical patent/DK183590D0/da
Publication of DK183590A publication Critical patent/DK183590A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK183590A 1988-02-02 1990-08-01 Fremgangsmaade til reduktion af immunoglobulin e-responser DK183590A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15141388A 1988-02-02 1988-02-02
PCT/US1989/000285 WO1989006975A1 (fr) 1988-02-02 1989-01-30 Procede de reduction des reactions dues a l'immunoglobuline e

Publications (2)

Publication Number Publication Date
DK183590D0 DK183590D0 (da) 1990-08-01
DK183590A true DK183590A (da) 1990-09-27

Family

ID=22538655

Family Applications (1)

Application Number Title Priority Date Filing Date
DK183590A DK183590A (da) 1988-02-02 1990-08-01 Fremgangsmaade til reduktion af immunoglobulin e-responser

Country Status (20)

Country Link
US (1) US5676940A (fr)
EP (2) EP0397764A1 (fr)
JP (1) JPH03500050A (fr)
KR (1) KR900700132A (fr)
AT (1) ATE93144T1 (fr)
AU (1) AU629536B2 (fr)
CA (1) CA1341477C (fr)
DE (1) DE68908431T2 (fr)
DK (1) DK183590A (fr)
ES (1) ES2058490T3 (fr)
FI (1) FI903827A0 (fr)
HK (1) HK35196A (fr)
HU (1) HU211059B (fr)
IE (1) IE63097B1 (fr)
IL (1) IL89124A (fr)
MY (1) MY107079A (fr)
NZ (1) NZ227812A (fr)
PT (1) PT89573B (fr)
WO (1) WO1989006975A1 (fr)
ZA (1) ZA89766B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643427B2 (en) * 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
WO1991007986A1 (fr) * 1989-12-04 1991-06-13 Schering Corporation Methode de traitement de choc septique
ATE136906T1 (de) * 1989-12-20 1996-05-15 Schering Corp Antikörperantagonisten gegen humanes interleukin- 4
US5252677A (en) * 1990-11-20 1993-10-12 Mitsubishi Petrochemical Company Limited Functionalized olefin polymers
DE4137333A1 (de) * 1991-11-13 1993-05-19 W Prof Dr Sebald Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung
US5914110A (en) * 1993-09-07 1999-06-22 Smithkline Beecham Corporation Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US20020193575A1 (en) 1993-09-07 2002-12-19 Smithkline Beecham P.L.C. Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5597710A (en) * 1994-03-10 1997-01-28 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
US6919366B2 (en) 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
US6911462B2 (en) 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
US6759425B2 (en) 1999-10-21 2004-07-06 Avanir Pharmaceuticals Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
DK2990420T3 (en) 2000-05-26 2017-04-03 Immunex Corp USE OF INTERLEUKIN-4 RECEPTOR ANTIBODIES AND COMPOSITIONS THEREOF
CZ20032691A3 (en) 2001-03-12 2004-04-14 Avanir Pharmaceuticals Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
WO2004024655A2 (en) 2002-09-12 2004-03-25 Avanir Pharmaceuticals Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
PE20060560A1 (es) 2004-08-03 2006-06-27 Novartis Ag Anticuerpos de interleucina-4 humana
US10196616B2 (en) 2017-02-15 2019-02-05 The United States Of America, As Represented By The Secretary Of Agriculture Altered avian virus for in-ovo inoculation and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80678A (en) * 1985-11-19 1999-05-09 Schering Biotech Corp Human interleukin-4
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
EP0255547A1 (fr) * 1986-07-29 1988-02-10 Kishimoto, Tadamitsu, Prof. Anticorps monoclonaux spécifiques du récepteur de surface pour IgE, ainsi que des lignes de cellules hybrides produisant ces anticorps et leur utilisation
AU618317B2 (en) * 1987-12-31 1991-12-19 Tanox Biosystems, Inc. Unique antigenic epitopes on ige-bearing b lymphocytes

Also Published As

Publication number Publication date
EP0327283A1 (fr) 1989-08-09
MY107079A (en) 1995-09-30
HU211059B (en) 1995-10-30
AU629536B2 (en) 1992-10-08
IL89124A0 (en) 1989-08-15
FI903827A7 (fi) 1990-08-01
WO1989006975A1 (fr) 1989-08-10
PT89573B (pt) 1994-01-31
EP0327283B1 (fr) 1993-08-18
IL89124A (en) 1994-10-21
AU3038389A (en) 1989-08-25
CA1341477C (fr) 2005-03-29
IE890302L (en) 1989-08-02
IE63097B1 (en) 1995-03-22
ZA89766B (en) 1989-09-27
DE68908431T2 (de) 1993-12-23
JPH03500050A (ja) 1991-01-10
DE68908431D1 (de) 1993-09-23
HUT54214A (en) 1991-01-28
HK35196A (en) 1996-03-08
HU891044D0 (en) 1990-11-28
PT89573A (pt) 1989-10-04
DK183590D0 (da) 1990-08-01
ES2058490T3 (es) 1994-11-01
EP0397764A1 (fr) 1990-11-22
FI903827A0 (fi) 1990-08-01
ATE93144T1 (de) 1993-09-15
KR900700132A (ko) 1990-08-11
US5676940A (en) 1997-10-14
NZ227812A (en) 1991-09-25

Similar Documents

Publication Publication Date Title
DK183590A (da) Fremgangsmaade til reduktion af immunoglobulin e-responser
NL300387I1 (nl) Antilichaam tegen menselijke interleukine-6-receptor
NO980030D0 (no) Monoklonale antistoffer som binder CD40-L
FI954347L (fi) Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
DK81691A (da) Fremgangsmaade til forhindring eller reduktion af eosinofili
DK0504307T3 (da) Fremgangsmåde til behandling af septisk shock
DK355483A (da) Monoklonale antistoffer til krydsafstemning af humant vaev
DK0387873T3 (da) Anti-humant spermaantistof, fremstilling og anvendelse deraf
DK134487A (da) Monoklonalt antistof med affinitet for humant interleukin-2
FI924278A0 (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner.
FI924851A7 (fi) Monoklonaalisia IgM:n vastaisia vasta-aineita, niiden tuottaminen ja k äyttö sekä hybridoomia näiden tuottamista varten
ATE59860T1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment